Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang, KW Park, JY Cho, IJ Jang… - Cmaj, 2006 - Can Med Assoc
Background: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
[PDF][PDF] Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang, KW Park, JY Cho, IJ Jang… - CMAJ, 2006 - Citeseer
Background: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
JW Suh, BK Koo, SY Zhang, KW Park… - … Journal= Journal de …, 2006 - europepmc.org
Background Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
S Jung-Won, BK Koo, Z Shu-Ying… - Canadian Medical …, 2006 - search.proquest.com
Methods: In phase 1 of the study, we administered clopidogrel to 16 healthy volunteers who
had the CYP3A5 non-expressor genotype (* 3 allele) and 16 who had the CYP3A5 …
had the CYP3A5 non-expressor genotype (* 3 allele) and 16 who had the CYP3A5 …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang, KW Park, JY Cho… - CMAJ, 2006 - snucm.elsevierpure.com
Background: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang… - … journal= journal de …, 2006 - pubmed.ncbi.nlm.nih.gov
Background Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
[HTML][HTML] Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang, KW Park… - CMAJ: Canadian …, 2006 - ncbi.nlm.nih.gov
Background Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
JW Suh, BK Koo, SY Zhang, KW Park… - Canadian Medical …, 2006 - search.ebscohost.com
Background: Clopidogrel is a prodrug requiring metabolism by cytochrome P< sub> 45 0<
sub> 3 A (CYP< sub> 3 A) isoenzymes, including CYP< sub> 3 A< sub> 5, in order to be …
sub> 3 A (CYP< sub> 3 A) isoenzymes, including CYP< sub> 3 A< sub> 5, in order to be …
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
JW Suh, BK Koo, SY Zhang, KW Park, JY Cho, IJ Jang… - 2006 - s-space.snu.ac.kr
BACKGROUND: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
(CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether …
[引用][C] Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
SUH JW - CAMJ, 2006 - cir.nii.ac.jp